A team of Galenica collegues will be attending CPhI Worldwide in Milan on 9th to 10th November 2021. To arrange a meeting during the event please contact firstname.lastname@example.org.
About Pernilla Hansson Gladh
This author has yet to write their bio.
Meanwhile lets just say that we are proud Pernilla Hansson Gladh contributed a whooping 7 entries.
Visit Kristina Thored, VP R&D, and Lars Wannerberger, Director Business Development to discuss opportunities.
Read more about Galenica in an article in Aftonbladet where our CEO Ronnie Wallin is interviewed about the work behind our product Oviderm.
As part of our efforts for continued medical education and best practice sharing, Galenica recently sponsored an online training module in collaboration with internetmedicin.se, Meducate and dermatologist Mats Berg, Skindoc/Danderyd. The training is based on a patient case where questions and comments will serve to share how to address the needs of people suffering from […]
Galenica is proud to finally launch www.oviderm.se – a website for one of our products!
Galenica is enjoying new spacious facilities at Medeon where there is possibility to grow even more in the future. Read more about Galenica here in an article produced by Wihlborgs.
On December 7, 2020 Biofrontera Pharma GmbH and Galenica AB signed an exclusive license and supply agreement for the marketing of both Ameluz® and BF-RhodoLED® in Sweden, Norway, Denmark, Finland and Iceland. Galenica AB hereby receives exclusive distribution rights for the Nordic regions, whereby Biofrontera will supply Ameluz® to Galenica. Biofrontera will be responsible for the […]